Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENDS as a Smoking Cessation Treatment
NCT02487953Phase 2Withdrawn
- Sponsor
- Duke University
- Start
- Jul 2018
- Primary completion
- Jan 2020
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nicotine patch in nicotine dependence, sponsored by Duke University. Planned start Jul 2018; status: withdrawn.
02
Drugs
nicotine patch
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT02487953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02487953.